156361-02-3 Usage
General Description
6-AMINO-5-CHLORO-NICOTINONITRILE is a chemical compound with the molecular formula C6H4ClN3. It is a derivative of nicotinonitrile, which is used as a building block in the synthesis of various pharmaceutical compounds. This chemical is an important intermediate in the production of several drugs and agrochemicals. It is known for its potential use in pharmaceutical research and development, particularly in the creation of new drugs for the treatment of various diseases. 6-AMINO-5-CHLORO-NICOTINONITRILE is also used in the synthesis of active pharmaceutical ingredients and in the development of new materials for use in the pharmaceutical and agrochemical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 156361-02-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,6,3,6 and 1 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 156361-02:
(8*1)+(7*5)+(6*6)+(5*3)+(4*6)+(3*1)+(2*0)+(1*2)=123
123 % 10 = 3
So 156361-02-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H4ClN3/c7-5-1-4(2-8)3-10-6(5)9/h1,3H,(H2,9,10)
156361-02-3Relevant articles and documents
Rh/Pd catalysis with chiral and achiral ligands: Domino synthesis of aza-dihydrodibenzoxepines
Friedman, Adam A.,Panteleev, Jane,Tsoung, Jennifer,Huynh, Vaizanne,Lautens, Mark
supporting information, p. 9755 - 9758 (2013/09/23)
A game of dominoes: A synthetic route to aza-dihydrodibenzoxepines is described, through the combination of a Rh-catalyzed arylation and a Pd-catalyzed C-O coupling in a single pot. For the first time, the ability to incorporate a chiral and an achiral ligand in a two-component, two-metal transformation is achieved, giving the products in moderate to good yields, with excellent enantioselectivities. Copyright
NOVEL BI-ARYL AMINES
-
Page/Page column 27, (2008/06/13)
The present invention relates to novel bi-aryl amines of formula (I) and to pharmaceutically acceptable prodrugs, salts, solvates, hydrates, and N-oxides thereof and to pharmaceutical compositions comprising them, methods of their use, and methods of their preparation.
